menu
    • menu

    Company profile for Ascent Pharmaceuticals

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ascent Pharmaceuticals is committed to providing patients with high-quality, cost-effective medicines that positively impact their lives. Through our work and products, we contribute to enhancing the quality of life for those we serve. We uphold the highest ethical standards, inspire our colleagues, and are driven to achieve our objectives. With a passionate team and a highly focused work environment, we deliver results that m...
    Ascent Pharmaceuticals is committed to providing patients with high-quality, cost-effective medicines that positively impact their lives. Through our work and products, we contribute to enhancing the quality of life for those we serve. We uphold the highest ethical standards, inspire our colleagues, and are driven to achieve our objectives. With a passionate team and a highly focused work environment, we deliver results that motivate and make a meaningful difference in healthcare.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ascent PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 S. Technology Dr Central Islip, NY 11722
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ascentpharm.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ascent’ Generics Buprenorphine & Naloxone Receives Approval in US
    Ascent’ Generics Buprenorphine & Naloxone Receives Approval in US

    15 Dec 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219727

    FDA
    15 Dec 2025
    Share Share
    Ascent’s Generics Sodium Oxybate Receives Approval in US
    Ascent’s Generics Sodium Oxybate Receives Approval in US

    05 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210523

    FDA
    05 Nov 2025
    Share Share
    Ascent`s Generics Rivaroxaban Receives Approval in US
    Ascent`s Generics Rivaroxaban Receives Approval in US

    14 May 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219332

    FDA
    14 May 2025
    Share Share
    Ascent Pharma`s Generics Carbidopa, Levodopa Receives Approval in US
    Ascent Pharma`s Generics Carbidopa, Levodopa Receives Approval in US

    14 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218939

    FDA
    14 Jan 2025
    Share Share
    Ascent Pharma`s Generics Lubiprostone Receives Approval in US
    Ascent Pharma`s Generics Lubiprostone Receives Approval in US

    02 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218640

    FDA
    02 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search